Fosun Pharma (02196.HK): The drug registration application for sodium succinate injection has been accepted by the National Medical Products Administration.

Smart Finance News App: Fosun Pharma (02196.HK) has announced that its subsidiary, Suzhou Erye Pharmaceutical Co., Ltd., a holding company of Shanghai Fosun Pharmaceutical Group, has had its drug registration application for Heparin Sodium Injection (referred to as "the drug") accepted by the National Medical Products Administration.